Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 6 Pancreatic Neoplasms 3 Pancreatic Cyst 2 Breast Neoplasms 2 Wilms Tumor 1 Uveal Melanoma 1 Thyroid Nodule 1 Thyroid Diseases 1 Prostatic Neoplasms 1 Peutz-Jeghers Syndrome 1 Pancreatitis, Chronic 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Intestinal Neuroendocrine Tumor 1 Hyperthyroidism 1 Hip Fractures 1 Hematologic Neoplasms 1 Goiter 1 Glioma 1 Glioblastoma 1 Frailty 1 Fractures, Spontaneous 1

Interventions

X-Rays 9 Specimen Handling 8 Phantoms, Imaging 8 Magnetic Resonance Spectroscopy 8 Vincristine 5 Nuclear Medicine Department, Hospital 5 Biopsy 5 Doxorubicin 4 Etoposide 3 Dactinomycin 3 Cyclophosphamide 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 fludarabine 2 erdafitinib 2 ensartinib 2 cabozantinib 2 Temozolomide 2 Radiotherapy, Conformal 2 Radiotherapy 2 Radiation 2 LY3023414 2 Irinotecan 2 talazoparib 1 selinexor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Wilms Tumor × Data Collection × 1 year × Clear all

NCT04423484 2026-03-02

GFANEPHRO20

French Africa Pediatric Oncology Group

Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡